MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2024 Earnings Call Transcript March 18, 2025
MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.5.
Operator: Hello, everyone. And welcome to MiNK Therapeutics Fourth Quarter 2024 Financial Results Call. Please note that this call is being recorded. After the speaker’s prepared remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. I’d now like to hand the...
